Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
EJNMMI Research|December 22, 2018
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivoEmiko Desvaux, Alan Courteau, Pierre-Simon Bellaye, et al.
EJNMMI Research|September 20, 2021
[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR studyAlexandra Oudot, Alan Courteau, Mélanie Guillemin, et al.
Molecular Imaging and Biology|December 8, 2022
A Practical Quality Assurance Procedure for Data Acquisitions in Preclinical Simultaneous PET/MR SystemsAlan Courteau, John McGrath, Paul Michael Walker, et al.
Medical Physics|December 11, 2013
Application of the optically stimulated luminescence (OSL) technique for mouse dosimetry in micro-CT imagingJean-Marc Vrigneaud, Alan Courteau, Julien Ranouil, et al.
IEEE Transactions on Medical Imaging|September 21, 2020
Performance Evaluation and Compatibility Studies of a Compact Preclinical Scanner for Simultaneous PET/MR Imaging at 7 TeslaAlan Courteau, John McGrath, Paul Michael Walker, et al.
Pharmaceutics|November 11, 2022
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic HyperthermiaAlexandre M M Dias, Alan Courteau, Pierre-Simon Bellaye, et al.
Contrast Media & Molecular Imaging|December 6, 2018
Functionalization of Gadolinium Chelates Silica Nanoparticle through Silane Chemistry for Simultaneous MRI/64Cu PET ImagingVu-Long Tran, Vivek Thakare, Marco Natuzzi, et al.
RSC Advances|May 9, 2022
Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imagingVivek Thakare, Vu-Long Tran, Marco Natuzzi, et al.
Theranostics|February 24, 2025
Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapiesAlexandre Magno Maneschy Dias, Olivier Burgy, Mathieu Moreau, et al.
Leukemia|December 15, 2019
The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrestAlexandre Pichard, Sara Marcatili, Jihad Karam, et al.
Pageof 1